Cryo-Cell Intl Inc CCEL

$3.65 -0.50 (-12.05%)

Valuation

Market cap
33,460,000
Revenue TTM
$31,570,000
Net income TTM
$-2,430,000
PE ratio
0.00
Forward PE
—
Profit margin
-7.70%
Debt to equity
-0.45

Trading

Volume
16,700
Avg volume
28,946
Day's range
$3.65 – $4.46
Shares out
8,063,000
Stochastic %K
16%
Beta
0.50
Analysts
Hold
Price target
$8.50

Price

Company profile

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing...

Show more

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Industry
Medical Care Facilities
Sector
Healthcare
Phone
813 749 2100
Website
https://www.cryo-cell.com
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar, United States

Latest news

Stocktwits

mebanks Oct 12, 3:06 PM
$CCEL , if only could get some volume
1 replies
oterfesk1 Sep 22, 9:00 AM
$PDSB We just need some volume here. Spread the word, people! "Patrick Soon-Shiong Secures Board Seat at PDS Biotechnology with 19.9% Stake Patrick Soon-Shiong is a physician-entrepreneur and the founder of NantWorks, known for building and investing in biotech and immunotherapy companies. Through Nant Capital, he invests in and acquires securities and other assets, with a focus on healthcare innovation. He previously created and sold major biotech businesses and often aligns equity stakes with collaborative R&D plans." $TOPS $FBGL $QNME $STI $GDC $WAVE $SLXN $CCEL $GRML
0 replies
oterfesk1 Sep 22, 8:39 AM
$PDSB Some volume and this will fly! Spread the word, and lets get some $$$$$ $TOPS $FBGL $QNME $STI $GDC $WAVE $GRML $GURE $GLND $SEAT $CCEL $AEHL
0 replies
NVDAMillionaire Sep 9, 6:52 PM
$CCEL Brilliant piece that captures CCEL's situation perfectly. So if you want to update your understanding of CCEL or get to know CCEL better, this is essential reading. https://everyticker.com/quote/CCEL/analysis/cryo-cell-international-a-quality-niche-player-fighting-for-survival-amid-strategic-collapse-nyseamerican-ccel
0 replies
STACKD0E Aug 12, 7:50 PM
$BANL $CCEL $INBS 👁️
0 replies
SuperGreenToday Jun 5, 10:27 AM
$CCEL
0 replies
Reesifer Apr 28, 7:59 PM
$GLXG added 1.05 $CCEL added 1.43
1 replies
PenkeInvesting Apr 18, 8:18 PM
Fundamental analysis of $CCEL (CRYO CELL INTERNATIONAL INC) based on financial data and reported results. #CCEL
0 replies